SCHEMBL2654331

SCHEMBL2654331

CC(NNC(=O)c1ccccc1)c1ccc(C(=O)O)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.53
NPC1 O15118 3/20 0.49
RAB9A P51151 3/20 0.49
ALDH1A1 P00352 2/20 0.49
LMNA P02545 1/20 0.49
CTDSP1 Q9GZU7 1/20 0.47
PHGDH O43175 3/20 0.47
GPR139 Q6DWJ6 1/20 0.47
DAO P14920 1/20 0.45
TSHR P16473 1/20 0.45
NAPRT Q6XQN6 1/20 0.45
FFAR1 O14842 1/20 0.45
KDM4E B2RXH2 1/20 0.45
POLB P06746 1/20 0.45
ROCK2 O75116 1/20 0.44
RPS6KA5 O75582 1/20 0.44
MAP4K4 O95819 1/20 0.44
CDK1 P06493 1/20 0.44
CSF1R P07333 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benmoxin SCHEMBL54431 0.90 GPR139 (0.55) SMN1; SMN2NPC1RAB9AALDH1A1LMNA
Benmoxin SCHEMBL8759658 0.90 GPR139 (0.55) SMN1; SMN2NPC1RAB9AALDH1A1LMNA
Benmoxin SCHEMBL8760295 0.90 GPR139 (0.55) SMN1; SMN2NPC1RAB9AALDH1A1LMNA
SCHEMBL8759636 0.86 SMN1; SMN2 (0.72) SMN1; SMN2NPC1RAB9AALDH1A1LMNA
SCHEMBL8759672 0.86 SMN1; SMN2 (0.72) SMN1; SMN2NPC1RAB9AALDH1A1LMNA
SCHEMBL8760263 0.83 PTGS2 (0.60) SMN1; SMN2NPC1RAB9AALDH1A1KDM4E
SCHEMBL8760655 0.83 PTGS2 (0.60) SMN1; SMN2NPC1RAB9AALDH1A1KDM4E
SCHEMBL8760259 0.83 SMN1; SMN2 (0.49) SMN1; SMN2NPC1RAB9AALDH1A1LMNA
SCHEMBL2645369 0.82 SMN1; SMN2 (0.59) SMN1; SMN2NPC1RAB9AALDH1A1LMNA
SCHEMBL2642857 0.82 SMN1; SMN2 (0.59) SMN1; SMN2NPC1RAB9AALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1773330-A4 SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE MERCK & CO INC (US) 2009-01-21 EP disclosed
CN-101291912-A Pyrazole derivatives, compositions containing such compounds and methods of use MERCK & CO INC (US) 2008-10-22 CN disclosed
EP-1773330-A2 SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE Merck & Co., Inc. (US) 2007-04-18 EP disclosed
WO-2006014618-A2 SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE MERCK & CO., INC. (US) 2006-02-09 WO disclosed